291 related articles for article (PubMed ID: 19431147)
1. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
[TBL] [Abstract][Full Text] [Related]
2. Latent TGF-β binding proteins (LTBPs) 1 and 3 differentially regulate transforming growth factor-β activity in malignant mesothelioma.
Vehviläinen P; Koli K; Myllärniemi M; Lindholm P; Soini Y; Salmenkivi K; Kinnula VL; Keski-Oja J
Hum Pathol; 2011 Feb; 42(2):269-78. PubMed ID: 21106222
[TBL] [Abstract][Full Text] [Related]
3. Expression and release of the latent transforming growth factor beta binding protein by hepatocytes from rat liver.
Roth S; Schurek J; Gressner AM
Hepatology; 1997 Jun; 25(6):1398-405. PubMed ID: 9185759
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer.
Sterner-Kock A; Thorey IS; Koli K; Wempe F; Otte J; Bangsow T; Kuhlmeier K; Kirchner T; Jin S; Keski-Oja J; von Melchner H
Genes Dev; 2002 Sep; 16(17):2264-73. PubMed ID: 12208849
[TBL] [Abstract][Full Text] [Related]
5. Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1.
Saharinen J; Taipale J; Keski-Oja J
EMBO J; 1996 Jan; 15(2):245-53. PubMed ID: 8617200
[TBL] [Abstract][Full Text] [Related]
6. Disruption of LTBP-4 function reduces TGF-beta activation and enhances BMP-4 signaling in the lung.
Koli K; Wempe F; Sterner-Kock A; Kantola A; Komor M; Hofmann WK; von Melchner H; Keski-Oja J
J Cell Biol; 2004 Oct; 167(1):123-33. PubMed ID: 15466481
[TBL] [Abstract][Full Text] [Related]
7. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.
Bruna A; Darken RS; Rojo F; Ocaña A; Peñuelas S; Arias A; Paris R; Tortosa A; Mora J; Baselga J; Seoane J
Cancer Cell; 2007 Feb; 11(2):147-60. PubMed ID: 17292826
[TBL] [Abstract][Full Text] [Related]
8. Latent TGF-beta binding proteins (LTBPs)-1 and -3 coordinate proliferation and osteogenic differentiation of human mesenchymal stem cells.
Koli K; Ryynänen MJ; Keski-Oja J
Bone; 2008 Oct; 43(4):679-88. PubMed ID: 18672106
[TBL] [Abstract][Full Text] [Related]
9. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1.
Annes JP; Chen Y; Munger JS; Rifkin DB
J Cell Biol; 2004 Jun; 165(5):723-34. PubMed ID: 15184403
[TBL] [Abstract][Full Text] [Related]
10. MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1.
Tatti O; Vehviläinen P; Lehti K; Keski-Oja J
Exp Cell Res; 2008 Aug; 314(13):2501-14. PubMed ID: 18602101
[TBL] [Abstract][Full Text] [Related]
11. Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells.
Gramatzki D; Pantazis G; Schittenhelm J; Tabatabai G; Köhle C; Wick W; Schwarz M; Weller M; Tritschler I
Oncogene; 2009 Jul; 28(28):2593-605. PubMed ID: 19465936
[TBL] [Abstract][Full Text] [Related]
12. Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein.
Taipale J; Miyazono K; Heldin CH; Keski-Oja J
J Cell Biol; 1994 Jan; 124(1-2):171-81. PubMed ID: 8294500
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the expression pattern of the latent transforming growth factor beta binding protein isoforms in normal and diseased human liver reveals a new splice variant missing the proteinase-sensitive hinge region.
Michel K; Roth S; Trautwein C; Gong W; Flemming P; Gressner AM
Hepatology; 1998 Jun; 27(6):1592-9. PubMed ID: 9620332
[TBL] [Abstract][Full Text] [Related]
14. Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes.
Chen Y; Ali T; Todorovic V; O'leary JM; Kristina Downing A; Rifkin DB
J Mol Biol; 2005 Jan; 345(1):175-86. PubMed ID: 15567420
[TBL] [Abstract][Full Text] [Related]
15. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
[TBL] [Abstract][Full Text] [Related]
16. Latent transforming growth factor binding protein 4 (LTBP-4) is downregulated in human mammary adenocarcinomas in vitro and in vivo.
Mauel S; Kruse B; Etschmann B; von der Schulenburg AG; Schaerig M; Stövesand K; Wilcken B; Sterner-Kock A
APMIS; 2007 Jun; 115(6):687-700. PubMed ID: 17550376
[TBL] [Abstract][Full Text] [Related]
17. Subcellular localization of (latent) transforming growth factor beta and the latent TGF-beta binding protein in rat hepatocytes and hepatic stellate cells.
Roth-Eichhorn S; Kühl K; Gressner AM
Hepatology; 1998 Dec; 28(6):1588-96. PubMed ID: 9828223
[TBL] [Abstract][Full Text] [Related]
18. Sequential deposition of latent TGF-beta binding proteins (LTBPs) during formation of the extracellular matrix in human lung fibroblasts.
Koli K; Hyytiäinen M; Ryynänen MJ; Keski-Oja J
Exp Cell Res; 2005 Nov; 310(2):370-82. PubMed ID: 16157329
[TBL] [Abstract][Full Text] [Related]
19. MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma.
Grzmil M; Morin P; Lino MM; Merlo A; Frank S; Wang Y; Moncayo G; Hemmings BA
Cancer Res; 2011 Mar; 71(6):2392-402. PubMed ID: 21406405
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a new latent transforming growth factor-beta-binding protein, LTBP-4.
Saharinen J; Taipale J; Monni O; Keski-Oja J
J Biol Chem; 1998 Jul; 273(29):18459-69. PubMed ID: 9660815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
